[Gallbladder cancer with elevated serum α-fetoprotein, α-fetoprotein-L3, and human chorionic gonadotropin levels].

MLA

Goto, Akira, et al. “[Gallbladder Cancer with Elevated Serum α-Fetoprotein, α-Fetoprotein-L3, and Human Chorionic Gonadotropin Levels].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 41, no. 8, Aug. 2014, pp. 1021–25. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=25132038&authtype=sso&custid=ns315887.

APA

Goto, A., Ishimine, Y., Hirata, T., Naito, T., Yabana, T., Adachi, T., Kondo, Y., & Kasai, K. (2014). [Gallbladder cancer with elevated serum α-fetoprotein, α-fetoprotein-L3, and human chorionic gonadotropin levels]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 41(8), 1021–1025.

Chicago

Goto, Akira, Yu Ishimine, Tsubasa Hirata, Takafumi Naito, Takashi Yabana, Takeya Adachi, Yoshihiro Kondo, and Kiyoshi Kasai. 2014. “[Gallbladder Cancer with Elevated Serum α-Fetoprotein, α-Fetoprotein-L3, and Human Chorionic Gonadotropin Levels].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 41 (8): 1021–25. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=25132038&authtype=sso&custid=ns315887.